ACE2 and severe acute respiratory syndrome: He et al. [24] published a paper in 2006 studying the post-mortem samples and clarified several important questions about the SARS-CoV infection, describing that ACE2-expressing cells were the primary targets for the SARS-CoV infection and, after the infection, the same cells produced high levels of pro-inflammatory cytokines, generating immuno-mediated damage.